The U.K.'s Acambis has won a $425 million contract to supply the CDC with its smallpox vaccine for 10 years. Acambis will establish a U.S.-based manufacturing capability for ACAM2000 and deliver a minimum of nine million doses per year of the drug. "The net proceeds will enable us to invest in manufacturing facilities for the U.S. contract, progress our vaccine for hospital-acquired C.difficile infections and further our program of new vaccines against influenza, genital herpes and other significant unmet medical needs," Acambis head Ian Garland told ShareCast.

- see the Acambis release [1]
- read this report [2] from ShareCast

Related Articles:
Sanofi buys into Acambis' West Nile vaccine program [3]
Acambis' universal vaccine begins human clinical trials [4]
Acambis shares plunge after U.S. nixes contract [5]
Acambis completes vaccine BLA [6]
Acambis researching single-shot solution to flu [7]